Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Et Ante Donec Rutrum Integer Amet Ligula Vel Imperdiet Eu Viverra Eget
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

Nunc libero etiam enim
By

By
Aenean eleifend ante maecenas pulvinar montes lorem et pede dis dolor pretium donec dictum. Vici consequat justo enim. Venenatis eget adipiscing luctus lorem. Adipiscing veni amet luctus enim sem libero…

DCAT Week ’18: Lonza Updates Integration of $5.5-Billion Acquisition of Capsugel
By

By
  Joseph ColleluoriSenior Vice President, Commercial DevelopmentLonza Pharma & Biotech Joseph Colleluori, Senior Vice President, Commercial Development, Lonza Pharma & Biotech and DCAT Past President, provided an update of the…

DCAT Week ’18: SK biotek Outlines Integration of Former BMS API Manufacturing Facility
By

By
  Nitin Parekh, PhDVice President and Executive Director, Strategy & BusinessSK biotek Nitin Parekh, PhD, Vice President and Executive Director, Strategy & Business of SK biotek, wholly owned subsidiary of…

DCAT Week ’18: PolyCrystalLine Expands Solid-State Chemistry Capabilities
By

By
  Stefano Giaffreda, PhDCEO and Co-FounderPolyCrystalLine Stefano Giaffreda, CEO and Co-Founder of PolyCrystalLine, a Bologna, Italy-based privately owned contract research organization (CRO) active in solid-state chemistry, announced a new and strategic…

DCAT Week ’18: Novasep Announces $65-Million Investment in Biologics
By

By
  Jean BléhautPresidentPresident, Manufacturing Solutions Business UnitNovasep In response to growing demand for specialized capabilities in biologics, Novasep is launching a series of major projects to boost its biomanufacturing capacity…

DCAT Week ’18: Procos CEO Outlines Expansion for High-Potency Manufacturing
By

By
  Enrico ZodioCEOProcos S.p.A. In 2018, Procos SpA will launch its GMP manufacturing unit dedicated to high-potency active pharmaceutical ingredients (HPAPI) at its facility in Cameri, Italy, located near Milan.…

DCAT Week ’18: Piramal Pharma Solutions CEO Outlines Expansion Plans
By

By
  Vivek SharmaCEOPiramal Pharma Solutions Vivek Sharma, chief executive officer of Piramal Pharma Solutions (PPS), a contract development and manufacturing organization, outlined an ongoing approximate $90-mllion investment plan to support…

DCAT Week ’18: DowDuPont Outlines Integration of Combined Company, Including Excipients Business
By

By
  Angela Strzelecki Global Business Director, Pharma Excipients, DuPont Nutrition & HealthDowDuPont Angela Strzelecki, Global Business Director for Pharmaceutical Excipients at DuPont Nutrition & Health, part of DowDuPont, the combined company…

DCAT Week ’18: Biocon COO Highlights Company’s Growth Strategy
By

By
  Prasad BSVChief Operating OfficerBiocon Limited Prasad BSV, Chief Operating Officer (COO), Biocon Limited, discussed the company’s growth strategy to add solid-dosage manufacturing capabilities to complement the company’s current position…